Andrew Scorey is the new SVP of Chr. Hansen’s Human Health business, and is part of the Health & Nutrition leadership team, reporting to Christian Barker, Executive Vice President Health & Nutrition.
“Probiotics for dietary supplements and infant formula is an attractive growth market that plays an important role in our future growth strategies. We have exciting opportunities ahead in our Human Health business that include bringing new products to market, further penetrating the infant segment, and continuing to drive growth in emerging markets,” explains Christian Barker.
“At the same time, we will continue to work with our customers to adapt to a new consumer landscape where online shopping is increasingly prevalent. I am convinced that Andrew is the right person to lead the Human Health business in capturing these opportunities,” adds Barker.
A seasoned leader
Andrew Scorey (50) is an experienced global consumer health executive, who has built an international career in a variety of senior leadership roles across the world.
In his most recent position, Andrew was CEO of Abbott Nutrition Greater China and prior to this he held a number of roles of increasing responsibility within marketing and general management at Abbott, Nestlé Nutrition, and Novartis Consumer Health. Andrew has experience spanning the Infant Nutrition, Consumer Health (Over the Counter) and pharmaceutical sectors.
“In addition to being a seasoned people leader and developer, Andrew brings a lot of relevant experience to Chr. Hansen, including the infant and consumer health space, global consumer understanding, (digital) consumer and Key Opinion Leader marketing, and hands-on experience from many of our markets across the world,” adds Barker.
Scorey is looking forward to being part of the Chr. Hansen journey:
“Chr. Hansen has a unique position within the global probiotics industry with many opportunities on the road ahead. I look forward to working with the team at Chr. Hansen to capture these, combining our strong science and production backbone with consumer insights and customer relationships. I know that Chr. Hansen puts a great focus on Innovation and I too feel that this is a requirement for long term success,” says Scorey.
As Scorey on boards, we will also be saying goodbye and thank you to Lasse Nagell who has decided to seek new opportunities after 12 years with Chr. Hansen.
Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, cleaner labels and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As the world’s most sustainable biotech company, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.